Skip to content

Music Therapy is Associated With Decreased Pain and Agitation in Intubated ICU Patients

Music Therapy is Associated With Decreased Pain and Agitation in Intubated ICU Patients

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01316536
Enrollment
5
Registered
2011-03-16
Start date
2010-04-30
Completion date
2013-12-31
Last updated
2015-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Music Therapy for Pain and Sedation

Keywords

pain, agitation, music

Brief summary

The study is designed to analyze the use of music therapy to decrease pain and agitation in intubated ICU patients.

Detailed description

This is a randomized, prospective single-blinded placebo-controlled study of consecutive intubated ICU patients requiring anxiolytics and analgesic medications. Patients will be randomized into two groups: one group will receive music (MUSIC), whereas the other group (CONTROL) will wear headphones, but hear an audio loop of recorded ICU sounds (vent alarms, ambient noise, talking, etc). The two groups will then be analyzed for sedation and analgesia requirements; Ramsay sedation score, ICP in brain injured patients, ventilator days, ICU length of stay, hospital length of stay, mean arterial blood pressure (MAP).

Interventions

OTHERprovide headphones with music playing

Participants will be provided with music through headphones

OTHERSounds

recorded ICU sounds will be provided to participants through headphones

Sponsors

University of California, San Francisco
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Caregiver)

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* between 18 and 70 years old, requiring intubation andmechanical ventilation, requiring sedation with propofol or benzodiazepines and/or analgesia with narcotics

Exclusion criteria

* hearing loss, psychiatric illness, hemodynamically unstable (requirement for vasopressor support)

Design outcomes

Primary

MeasureTime frame
Decreased sedation and pain requirementsmaximum of 7 days from study entry while still intubated and sedated

Secondary

MeasureTime frame
ICU length of stayfrom admission date to ICU to discharge date from ICU while on study

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026